Back to search

University of Southampton

Investigating the function and therapeutic potential of a novel human myeloid checkpoint receptor, LILRB3 (ILT5)

Abstract

dc:description.abstract

The human leukocyte immunoglobulin-like receptor (LILR) B3 belongs to the immune inhibitory subfamily of LILRs. LILRB3 contains four immunoreceptor tyrosine-based inhibitory motifs in its cytoplasmic domain, which recruit phosphatases to abrogate the propagation of activatory signalling cascades. Despite its discovery in the late 1990s, its function on myeloid cells and therapeutic potential has not been elucidated. <br/><br/>As LILRB3 is only expressed in humans, a transgenic (Tg) mouse was generated to investigate its function alongside human antibodies specific for the receptor. LILRB3 expression in the Tg mouse recapitulated that in healthy human blood and confirmed its restricted expression on myelomonocytic cells, while being absent on lymphocytes. Our studies revealed previously unknown immunoinhibitory functions of LILRB3 in myeloid cells and suggest its potential as a novel myeloid checkpoint inhibitor.<br/><br/>Having confirmed the expression and immunoinhibitory function of LILRB3 in humans and in the LILRB3 Tg mouse model, the therapeutic potential of the receptor as a target for immunotherapy for acute myeloid leukaemia (AML) was investigated. Collectively, our data demonstrated that LILRB3 is a viable target for AML immunotherapy, providing impetus to further explore this potential new therapy in vivo and in AML patients.<br/>

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Papagregoriou, Charys
Advisor dc:contributor.advisor
  • Roghanian, Ali
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Papagregoriou, Charys. Investigating the function and therapeutic potential of a novel human myeloid checkpoint receptor, LILRB3 (ILT5). doctoral thesis, University of Southampton, 2022.